AT1 10.0% 2.2¢ atomo diagnostics limited

AT1 FY21 - General Discussion + FA, page-1935

  1. 1,209 Posts.
    lightbulb Created with Sketch. 646
    LDX Q2 FY22 report out earlier today. Cash receipts of US$1.6m last qtr and its unclear how much of this was from FebriDx sales (non-US geos), though its won't be much in any case. Global $ still focussed v much on Covid19 related tests, treatments and vaccines.

    Extract about FebriDx:

    https://hotcopper.com.au/data/attachments/4038/4038020-d431fd4d86783718fb27582d19b251be.jpg

 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.